Results 51 to 60 of about 1,692 (164)
Cancer Medicine, Volume 15, Issue 6, June 2026.ABSTRACT Background Persistent infection with high‐risk human papillomavirus (HR‐HPV) is defined as the principal cause of cervical cancer. Given the important role of cervicovaginal microbiota in HPV acquisition and disease progression, this study aims to evaluate the clinical efficacy of the probiotic Enterococcus faecium (E.
Jun Yang +6 more
wiley +1 more source
Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception
Gynecological Endocrinology, 2023 The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think about treatment adherence, and to compare the gynecologists' opinions with the patients' own perceptions within the CRETA study.Spanish gynecologists who ...
María J. Cancelo +8 more
openaire +3 more sources
Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter
Animal Models and Experimental Medicine, Volume 9, Issue 4, Page 752-764, April 2026.Clotrimazole‐loaded PLGA microparticles for intravaginal delivery. Abstract Background Intravaginal drug administration is the most promising strategy for treating vaginal infections to protect women's health, such as vulvovaginal candidiasis (VVC). However, conventional vaginal formulations in the clinic face challenges such as drug leakage and low ...
Yanyu Li +8 more
wiley +1 more source
Modern approach to the management of genitourinary syndrome in women with gynecological malignancies
Radiology and Oncology, 2023 The term genitourinary syndrome of menopause was first used in 2014 by the North American Menopause Society and the International Society for the Study of Women's Sexual Health to describe conditions previously known as atrophic vaginitis, urogenital ...
Kovacevic Nina +3 more
doaj +1 more source
Oncosexology: A Narrative Review on Sexual Health and Quality of Life in Cancer Patients
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Cancer remains a major global public health problem. A key aspect of cancer care among survivors is sexual health. Cancer patients experience a range of sexual dysfunctions, including erectile dysfunction, vaginal dryness, dyspareunia, and reduced libido.
Pasquale Marino +8 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 521-524, April 2026.Abstract Objective To compare the efficacy and safety of fractional microablative radiofrequency (RF) and topical estriol in the treatment of genitourinary syndrome of menopause (GSM). Methods This pilot randomized controlled trial included 30 healthy postmenopausal women with GSM.
Priscila de Almeida Torre +6 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 99-108, April 2026.Abstract Background Breast cancer survivors (BCS) often experience more severe symptoms of genitourinary syndrome of menopause (GSM). As estrogen‐based hormonal therapy is generally avoided in BCS, physical energy methods may offer promising non‐hormonal alternatives.
Nicoli Serquiz +7 more
wiley +1 more source
Evidence‐ and consensus‐based guideline on lichen sclerosus
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-584, April 2026.Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig +25 more
wiley +1 more source
Elasticity Improvement and Water Loss Prevention in Vulvar Skin by Topical Nonhormonal Moisturizer
JEADV Clinical Practice, Volume 5, Issue 1, Page 117-123, March 2026.Effect of topical non‐hormonal moisturizer on the vulva in postmenopausal women. Moisturizer is completely absorbed. Water loss from vulva is reduced by 51% compared to baseline measurements. Elasticity is improved by 21% compared to baseline measurements.
Hans Christian Wulf +2 more
wiley +1 more source
Respirology Case Reports, Volume 14, Issue 3, March 2026.Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar +4 more
wiley +1 more source